Financials
- Market Capitalization 13.15 M
- Employee 6
- Founded 2009
- CEO N/A
- Website www.kalarx.com
- Headquarter Delaware, United States
- FIGI BBG001J2MVT8
- Industry Biotechnologie
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 4669 | AEON AEON Biopharma, Inc. Class A Common Stock | 0.29 USD | -6.45% | +52.63% | 0.00% | -72.12% | 14.47 M USD | ||
| 4673 | PASG Passage Bio, Inc. - Common Stock | 4.52 USD | +4.39% | +2.49% | +0.89% | -48.87% | 14.54 M USD | ||
| 4679 | LSTA Lisata Therapeutics, Inc. - Common Stock | 1.58 USD | -6.51% | -11.24% | +59.60% | -30.40% | 14.24 M USD | ||
| 4689 | INTS Intensity Therapeutics, Inc. - Common Stock | 4.20 USD | -1.18% | -11.58% | +2.69% | +1400.00% | 13.71 M USD |